Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female
- People who are 18 years of age or older
- People who have been recently diagnosed with breast cancer (confirmed by tissue testing) at stages IA through IIIC
- People who are planned to receive chemotherapy before surgery, using anthracycline or taxane-based drugs, which may also include targeted treatments for HER2-positive breast cancer
- People who are being cared for by the oncology department at CHVNG/E (a specific hospital centre)
- People whose cancer doctor has approved participation in a physical exercise program
- People who are able to give written consent to take part in the study
- People who agree to be randomly assigned to either the exercise group or the comparison group
Who may not be able to join:
- People who have had a cancer diagnosis in the past
- People who currently have another cancer diagnosis at the same time
- People who have a physical or mental health condition that means exercise would not be safe or appropriate for them
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nuno Rato, MSc, University of Maia
Phone: +351 919985852
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathologic Complete Response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.